Figures & data
Table 1 Demographic data and clinical measures for the cervical spondylotic myelopathy patients and healthy controls
Figure 1 The scatter plot with duration of symptoms and JOA score of CSM patients.
![Figure 1 The scatter plot with duration of symptoms and JOA score of CSM patients.](/cms/asset/45b424b7-f6c7-4ed6-ae15-d2ca56d38d77/dndt_a_209952_f0001_b.jpg)
Table 2 zALFF and zReHo differences between the two groups (P<0.01, cluster-wise FDR corrected)
Figure 2 zALFF and zReHo differences between the two groups (P<0.01, cluster-wise FDR corrected). Red-yellow spots, CSM>HC.
![Figure 2 zALFF and zReHo differences between the two groups (P<0.01, cluster-wise FDR corrected). Red-yellow spots, CSM>HC.](/cms/asset/77881415-adc2-49b5-8bf9-a86f812b9f8d/dndt_a_209952_f0002_c.jpg)
Table 3 Functional connectivity differences between the two groups (P<0.01, cluster-wise FDR corrected)
Figure 3 Functional connectivity differences between the two groups, lSFGmed selected as seed ROI (P<0.01, cluster-wise FDR corrected). Red-yellow spots, CSM>HC; blue spots, CSM<HC.
![Figure 3 Functional connectivity differences between the two groups, lSFGmed selected as seed ROI (P<0.01, cluster-wise FDR corrected). Red-yellow spots, CSM>HC; blue spots, CSM<HC.](/cms/asset/9dd0eb32-cd29-4fb1-9d4f-bf38b0f65953/dndt_a_209952_f0003_c.jpg)
Figure 4 Functional connectivity differences between the two groups, lSMG selected as seed ROI (P<0.01, cluster-wise FDR corrected). Red-yellow spots, CSM>HC.
![Figure 4 Functional connectivity differences between the two groups, lSMG selected as seed ROI (P<0.01, cluster-wise FDR corrected). Red-yellow spots, CSM>HC.](/cms/asset/54275965-797e-4908-8b79-7cb38c257267/dndt_a_209952_f0004_c.jpg)
Table 4 Correlation between altered zALFF, zReHo, and functional connectivity with clinical measures in the CSM group